| Rank | Clinic Name | Patient Rating | Country | Lead Doctor | experience | Techniques | Best For | Why It’s Ranked | Accreditations |
|---|---|---|---|---|---|---|---|---|---|
| #1 | — / 5 | Shenzhen, China | — | — | Mesenchymal stem cell therapy, intravenous injection, intrathecal injection, high-potency stem cell injection protocol | MS patients seeking umbilical cord stem cell therapy | Uses umbilical cord stem cells to regulate immune attack and support remyelination. Combined IV and intrathecal delivery with 120–400 million cells. AABB and CAP accredited. Published outcomes: 56% of patients report physical improvement. | ISO 9001:2015 Quality management systems |